Dolby Laboratories에 대한 매도 수량은 투자자에게 Dolby Laboratories의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Dolby Laboratories (NYSE:DLB) 주식, 공매도 수량 보고

Dolby Laboratories

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Earnings

News

Guidance

Movers

돌리 래버러토리스(NYSE:DLB)는 화요일(19일) 장 마감 후 2024회계연도 4분기 실적을 다음과 같이 발표했다. 4분기 매출: 3억 4,800만 달러, 예상치 3억 7,900만 달러 하회4분기 조정 주당순이익: 81센트, 예상치 70센트 상회

돌비 래버러토리스 4분기 호실적 및 강력한 전망 제시, 시간외 14% 급등

Dolby Laboratories Inc

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) reported financial results for the fourth quarter of fiscal 2024 after the bell on Tuesday. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/24/11/n42074717/dolby-laboratories-reports-fourth-quarter-and-fiscal-year-2024-financial-results">from the quarter</a>.
<ul>
<li>Q4 Revenue: $304.81 million, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $307.94 million</li>
</ul>
<ul>
<li>Q4 Adjusted EPS: 81 cents, versus estimates of 70 cents</li>
</ul>
Dolby said it repurchased approximately 251,000 shares during the quarter. The company had approximately $402 million remaining under its stock repurchase authorization at the quarter&#8217;s end. The company also declared a cash dividend of 33 cents per share payable on Dec. 10 to shareholders of record as of Dec. 3.
&#8220;As we enter fiscal 2025, we have strong momentum with Dolby Atmos and Dolby Vision, our imaging patent portfolio has gotten stronger with the GE Licensing acquisition, and we are excited about our opportunity with Dolby.io, which is well positioned to provide real-time interactive experiences for sports and entertainment,&#8221; said Kevin Yeaman, president and CEO of Dolby.
Don&#8217;t Miss: <a href="https://www.benzinga.com/24/11/42073589/target-q3-earnings-preview-analysts-expect-revenue-eps-growth-attention-may-quickly-turn-to-holiday-quarter">Target Q3 Earnings Preview: Analysts Expect Revenue, EPS Growth As Attention Turns To Holiday Quarter</a>
Outlook: Dolby expects first-quarter revenue to be in the range of $330 million to $360 million versus estimates of $307.94 million. The company anticipates first-quarter earnings of 96 cents to $1.11 per share versus estimates of 70 cents per share.
Dolby sees full-year 2025 revenue in the range of $1.33 billion to $1.39 billion versus estimates of $1.28 billion. The company expects full-year earnings to be between $3.99 and $4.14 per share versus estimates of $3.70 per share. 
Dolby&#8217;s strong forecast appears to be helping push shares higher after hours. The company&#8217;s management team will further discuss the quarter on a call with analysts and investors at 5 p.m. ET.
DLB Price Action: Dolby shares were up 11.06% in after hours, trading at $78.75 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Pixabay.

Dolby Laboratories Reports Q4 Earnings, Provides Strong Forecast For 2025, Shares Surge

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) is looking for Q1 Adj EPS of $0.96-1.11 vs $0.70 analyst estimate. sees sales of $330.000 million-360.000 million vs $307.94 million estimate.

Dolby Laboratories Sees Q1 Adj EPS $0.96-1.11 vs $0.70 Est; Sees Sales $330.000M-360.000M vs $307.94M Est

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) is looking for FY2025 Adj EPS of $3.99-4.14 vs $3.70 analyst estimate. sees sales of $1.330 billion-1.390 billion vs $1.28 billion estimate.

Dolby Laboratories Sees FY2025 Adj EPS $3.99-4.14 vs $3.70 Est; Sees Sales $1.330B-1.390B vs $1.28B Est

WIIM

Dolby Laboratories shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results and issued FY25 EPS guidance above estimates.

Dolby is providing the following estimates for the full year of fiscal 2025:
<ul>
<li>Total revenue is expected to range from $1.33 billion to $1.39 billion.</li>
<li>Gross margins are anticipated to be approximately 87% on a GAAP basis and approximately 90% on a non-GAAP basis.</li>
<li>Operating expenses are anticipated to range from $908 million to $918 million on a GAAP basis and from $765 million to $775 million on a non-GAAP basis.</li>
<li>Dolby expects operating margins to be roughly 20% on a GAAP basis and to be roughly 33% on a non-GAAP basis.</li>
<li>Diluted earnings per share is anticipated to range from $2.43 to $2.58 on a GAAP basis and from $3.99 to $4.14 on a non-GAAP basis.</li>
</ul>

Dolby Laboratories Sees FY25 EPS $3.99-$4.14 Vs $3.80 Est.; Revenue $1.33B-$1.39B Vs $1.33B Est.

Dolby is providing the following estimates for its first quarter of fiscal 2025:
<ul>
<li>Total revenue is estimated to range from $330 million to $360 million.</li>
<li>Licensing revenue is estimated to range from $305 million to $335 million.</li>
<li>Gross margins are anticipated to be approximately 87% on a GAAP basis and approximately 90% on a non-GAAP basis.</li>
<li>Operating expenses are anticipated to range from $230 million to $240 million on a GAAP basis and from $190 million to $200 million on a non-GAAP basis.</li>
<li>Effective tax rate is anticipated to be around 20.5% on a GAAP basis and around 18.5% on a non-GAAP basis.</li>
<li>Diluted earnings per share is anticipated to range from $0.53 to $0.68 on a GAAP basis and from $0.96 to $1.11 on a non-GAAP basis.</li>
</ul>

Dolby Laboratories Sees Q1 EPS $0.96-$1.11 Vs $1.09 Est.; Revenue $330M-$360M Vs $337.96M Est.

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) reported quarterly earnings of $0.81 per share which beat the analyst consensus estimate of $0.70 by 15.71 percent. This is a 24.62 percent increase over earnings of $0.65 per share from the same period last year. The company reported quarterly sales of $304.81 million which missed the analyst consensus estimate of $307.94 million by 1.02 percent. This is a 4.90 percent increase over sales of $290.56 million the same period last year.

Earnings Beats

Earnings Misses

Dolby Laboratories Q4 Adj $0.81 Beats $0.70 Estimate, Sales $304.81M Miss $307.94M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Star Equity Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRR#NASDAQ">STRR</a>) is likely to report quarterly loss at $0.32 per share on revenue of $13.15 million. 
• EuroDry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDRY#NASDAQ">EDRY</a>) is projected to report quarterly loss at $0.23 per share on revenue of $19.14 million. 
• S&amp;W Seed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANW#NASDAQ">SANW</a>) is expected to report quarterly loss at $1.40 per share on revenue of $17.00 million. 
• GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) is likely to report quarterly loss at $0.21 per share on revenue of $415.42 million. 
• Valvoline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVV#NYSE">VVV</a>) is expected to report quarterly earnings at $0.42 per share on revenue of $432.47 million. 
• Energizer Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENR#NYSE">ENR</a>) is likely to report quarterly earnings at $1.17 per share on revenue of $805.43 million. 
• Jacobs Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) is likely to report quarterly earnings at $1.37 per share on revenue of $3.01 billion. 
• Kingsoft Cloud Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) is likely to report quarterly loss at $0.14 per share on revenue of $247.64 million. 
• Atour Lifestyle Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAT#NASDAQ">ATAT</a>) is expected to report quarterly earnings at $0.36 per share on revenue of $264.74 million. 
• MYT Netherlands Parent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYTE#NYSE">MYTE</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $203.93 million. 
• Lowe's Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) is expected to report quarterly earnings at $2.82 per share on revenue of $19.94 billion. 
• Vipshop Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIPS#NYSE">VIPS</a>) is projected to report quarterly earnings at $0.33 per share on revenue of $2.91 billion. 
• Weibo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WB#NASDAQ">WB</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $435.98 million. 
• Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) is estimated to report quarterly earnings at $0.53 per share on revenue of $167.72 billion. 
• Viking Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>) is expected to report quarterly earnings at $0.85 per share on revenue of $1.66 billion. 
• Danimer Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNMR#NYSE">DNMR</a>) is likely to report quarterly loss at $0.20 per share on revenue of $8.57 million. 
• Northern Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTIC#NASDAQ">NTIC</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $22.50 million. 
• Eltek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTK#NASDAQ">ELTK</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $12.40 million. 
• Futu Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>) is expected to report quarterly earnings at $0.97 per share on revenue of $347.63 million. 
• Allot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLT#NASDAQ">ALLT</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $22.80 million. 
• Elbit Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESLT#NASDAQ">ESLT</a>) is likely to report quarterly earnings at $1.86 per share on revenue of $1.61 billion. 
• XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) is estimated to report quarterly loss at $0.27 per share on revenue of $1.38 billion. 
• Amer Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AS#NYSE">AS</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $1.30 billion. 
• Medtronic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>) is projected to report quarterly earnings at $1.25 per share on revenue of $8.27 billion. 
• Oaktree Specialty Lending (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCSL#NASDAQ">OCSL</a>) is estimated to report quarterly earnings at $0.56 per share on revenue of $96.90 million. 
<h3>Companies Reporting After The Bell</h3>
• Workhorse Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) is projected to report quarterly loss at $0.82 per share on revenue of $4.68 million. 
• XP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XP#NASDAQ">XP</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $772.20 million. 
• AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) is likely to report quarterly earnings at $0.27 per share on revenue of $339.99 million. 
• Algorhythm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIME#NASDAQ">RIME</a>) is estimated to report earnings for its third quarter. 
• Sociedad Quimica Y Minera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQM#NYSE">SQM</a>) is likely to report quarterly earnings at $0.66 per share on revenue of $1.09 billion. 
• StoneX Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNEX#NASDAQ">SNEX</a>) is estimated to report quarterly earnings at $2.05 per share on revenue of $462.98 million. 
• Kore Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KORE#NYSE">KORE</a>) is estimated to report quarterly loss at $0.63 per share on revenue of $67.90 million. 
• ReNew Energy Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNW#NASDAQ">RNW</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $313.59 million. 
• Qifu Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QFIN#NASDAQ">QFIN</a>) is likely to report quarterly earnings at $1.42 per share on revenue of $588.49 million. 
• Star Bulk Carriers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBLK#NASDAQ">SBLK</a>) is expected to report quarterly earnings at $0.99 per share on revenue of $305.05 million. 
• Powell Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) is likely to report quarterly earnings at $3.55 per share on revenue of $286.49 million. 
• La-Z-Boy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LZB#NYSE">LZB</a>) is estimated to report quarterly earnings at $0.64 per share on revenue of $505.98 million. 
• Auna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUNA#NYSE">AUNA</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $297.67 million. 
• Varex Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VREX#NASDAQ">VREX</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $200.54 million. 
• Keysight Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) is likely to report quarterly earnings at $1.57 per share on revenue of $1.26 billion. 
• ZTO Express (Cayman) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTO#NYSE">ZTO</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $1.48 billion. 
• Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) is estimated to report quarterly earnings at $0.70 per share on revenue of $307.94 million. 
• Golub Capital BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBDC#NASDAQ">GBDC</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $234.39 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALLT

ATAT

AUNA

AZEK

DNMR

EDRY

ELTK

ESLT

FUTU

GBDC

KEYS

KORE

MYTE

NTIC

OCSL

POWL

QFIN

RIME

SANW

SBLK

SNEX

STRR

VIPS

VREX

WKHS

XPEV

Earnings Scheduled For November 19, 2024

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) is preparing to release its quarterly earnings on Tuesday, 2024-11-19. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Dolby Laboratories to report an earnings per share (EPS) of $0.70.
Anticipation surrounds Dolby Laboratories's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
During the last quarter, the company reported an EPS beat by $0.12, leading to a 7.18% drop in the share price on the subsequent day.
Here's a look at Dolby Laboratories's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.59</td>
<td>1.19</td>
<td>0.86</td>
<td>0.53</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.71</td>
<td>1.27</td>
<td>1.01</td>
<td>0.65</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-7.000000000000001%</td>
<td>3.0%</td>
<td>-5.0%</td>
<td>-7.000000000000001%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1731942092_0.png" alt="eps graph" />
<h3>Performance of Dolby Laboratories Shares</h3>
Shares of Dolby Laboratories were trading at $71.73 as of November 15. Over the last 52-week period, shares are down 14.65%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Observations about Dolby Laboratories</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Dolby Laboratories.
With 1 analyst ratings, Dolby Laboratories has a consensus rating of Outperform. The average one-year price target is $100.0, indicating a potential 39.41% upside.
<h3>Analyzing Ratings Among Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of OneStream, UiPath and CommVault Systems, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>The prevailing sentiment among analysts is an Outperform trajectory for OneStream, with an average 1-year price target of $36.0, implying a potential 49.81% downside.</li>
<li>UiPath received a Neutral consensus from analysts, with an average 1-year price target of $15.55, implying a potential 78.32% downside.</li>
<li>CommVault Systems received a Buy consensus from analysts, with an average 1-year price target of $185.67, implying a potential 158.85% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
In the peer analysis summary, key metrics for OneStream, UiPath and CommVault Systems are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dolby Laboratories</td>
<td>Outperform</td>
<td>-3.20%</td>
<td>$253.16M</td>
<td>1.58%</td>
</tr>
<tr>
<td>OneStream</td>
<td>Outperform</td>
<td>20.69%</td>
<td>$64.74M</td>
<td>-80.43%</td>
</tr>
<tr>
<td>UiPath</td>
<td>Neutral</td>
<td>10.07%</td>
<td>$252.93M</td>
<td>-4.46%</td>
</tr>
<tr>
<td>CommVault Systems</td>
<td>Buy</td>
<td>16.06%</td>
<td>$190.42M</td>
<td>5.56%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Dolby Laboratories ranks at the top for Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.
<h3>All You Need to Know About Dolby Laboratories</h3>
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
<h3>Dolby Laboratories: A Financial Overview</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Decline in Revenue: Over the 3 months period, Dolby Laboratories faced challenges, resulting in a decline of approximately -3.2% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Dolby Laboratories's net margin is impressive, surpassing industry averages. With a net margin of 13.31%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Dolby Laboratories's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 1.58%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Dolby Laboratories's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.28%, the company showcases efficient use of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.02.
<a href="https://www.benzinga.com/quote/DLB/earnings">To track all earnings releases for Dolby Laboratories visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Dolby Laboratories's Earnings: A Preview

Expands Arabic Content With New Series And Exclusive Concerts, Partners With UAE Telcos For 4K Streaming And Saudi Ministry Of Culture For Talent Development

AAPL

ANGH

Anghami Reports Strong 2024 Growth With 28% Increase In Video Streaming Engagement And 18% ARPU Rise; Launches AI-Driven Features, DolbyVision, And Apple Vision Pro App

Barrington Research analyst James Goss maintains Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) with a Outperform and maintains $100 price target.

Price Target

Analyst Ratings

Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $100 Price Target

RIVN

Rivian To Integrate Apple Music's Premium Spatial Audio With Dolby Atmos Support Into All Electric Vehicles For Apple Music Subscribers

Dolby Laboratories shares are trading lower after the company cut its Q4 guidance below estimates.

Financial Outlook
Dolby's financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products. In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates. The uncertainty resulting from these factors has greatly reduced its visibility into Dolby's future outlook. To the extent possible, the estimates Dolby is providing for future periods reflect certain assumptions about the potential impact of certain of these items, based upon a consideration of currently available external and internal data and information. These assumptions are subject to risks and uncertainties. For more information, see "Forward-Looking Statements" in this press release for a description of certain risks that Dolby faces, and the section captioned "Risk Factors" in its Quarterly Report on Form 10-Q for the third quarter of fiscal 2024, to be filed on or around the date hereof.
Dolby is providing the following estimates for its fourth quarter of fiscal 2024:
<ul>
<li>Total revenue is estimated to range from $300 million to $320 million.</li>
<li>Licensing revenue is estimated to range from $275 million to $295 million.</li>
<li>Gross margins are anticipated to be approximately 88%.</li>
<li>Operating expenses are anticipated to range from $225 million to $235 million on a GAAP basis and from $190 million to $200 million on a non-GAAP basis.</li>
<li>Effective tax rate is anticipated to be around 29% on a GAAP basis and around 23% on a non-GAAP basis.</li>
<li>Diluted earnings per share is anticipated to range from $0.31 to $0.46 on a GAAP basis and from $0.61 to $0.76 on a non-GAAP basis.</li>
</ul>
Dolby is providing the following estimates for the full year of fiscal 2024:
<ul>
<li>Total revenue is expected to range from $1.27 billion to $1.29 billion.</li>
<li>Gross margins are anticipated to be roughly 89%.</li>
<li>Operating expenses are anticipated to range from $875 million to $885 million on a GAAP basis and from $735 million to $745 million on a non-GAAP basis.</li>
<li>Dolby expects operating margins on a GAAP basis to be roughly 20% and on a non-GAAP basis to be roughly 31%.</li>
<li>Diluted earnings per share is anticipated to range from $2.40 to $2.55 on a GAAP basis and from $3.60 to $3.75 on a non-GAAP basis.</li>
</ul>

Dolby Laboratories Sees Q4 EPS $0.61-$0.76 Vs $0.85 Est.; Revenue $300M-$320M Vs $326.6M Est.; FY24 EPS $3.60-$3.75 Vs $3.72 Est.; Revenue $1.27B-$1.29B Vs $1.29B Est.

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.59 by 20.34 percent. The company reported quarterly sales of $288.818 million which beat the analyst consensus estimate of $286.183 million by 0.92 percent. This is a 3.20 percent decrease over sales of $298.370 million the same period last year.

Dolby Laboratories Q3 2024 Adj. EPS $0.71 Beats $0.59 Estimate, Sales $288.818M Beat $286.183M Estimate

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $98.5, a high estimate of $100.00, and a low estimate of $98.00. Observing a 0.51% increase, the current average has risen from the previous average price target of $98.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1717765245_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The perception of Dolby Laboratories by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steven Frankel</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$98.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>James Goss</td>
<td>Barrington Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$100.00</td>
<td>-</td>
</tr>
<tr>
<td>Steve Frankel</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$98.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Steve Frankel</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$98.00</td>
<td>$98.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Dolby Laboratories. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dolby Laboratories compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Dolby Laboratories's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Dolby Laboratories's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DLB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Dolby Laboratories analyst ratings.</a>
<h2>About Dolby Laboratories</h2>
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
<h3>Understanding the Numbers: Dolby Laboratories's Finances</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Decline in Revenue: Over the 3 months period, Dolby Laboratories faced challenges, resulting in a decline of approximately -3.02% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Dolby Laboratories's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 26.84%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 4.1%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Dolby Laboratories's ROA stands out, surpassing industry averages. With an impressive ROA of 3.27%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Dolby Laboratories's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.02.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What 4 Analyst Ratings Have To Say About Dolby Laboratories

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) with a Buy and maintains $98 price target.

Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target

Dolby Laboratories, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>), known for its entertainment services, announced a definitive agreement to acquire GE Aerospace&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) GE Licensing, which specializes in intellectual property licensing in the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/06/n39204581/dolby-laboratories-announces-agreement-to-acquire-ge-licensing-from-ge-aerospace" rel="noreferrer noopener">consumer digital media and electronics sectors.</a>
Dolby Laboratories will acquire GE Licensing in a $429 million all-cash transaction, expected to close by the end of fiscal year 2024.
The deal involves over 5,000 patents, including key patents in video compression technology. This acquisition will bolster Dolby&#8217;s patent portfolio, enhancing its standing in the industry.
GE Aerospace will retain its portfolio of IP related to its core aerospace and defense technologies, as well as the trademark portfolio for the GE brand.
GE Licensing is recognized for its innovations and patents, particularly in video codec technology. Andy Sherman, Dolby&#8217;s Executive Vice President, Patent Licensing and General Counsel, emphasized the strategic importance of this acquisition for Dolby&#8217;s commitment to open standards and collaborative licensing.
Robert Giglietti, CEO of Corporate Holdings and Treasurer at GE Aerospace, stated, &#8220;As GE Aerospace continues to sharpen its focus as a standalone company serving aerospace and defense customers, Dolby is the right partner for ensuring these innovative digital media technologies continue to serve businesses and consumers around the world.&#8221;
The deal, which awaits regulatory approval, will not significantly impact Dolby&#8217;s fiscal 2024 results. Dolby anticipates the acquisition to be accretive to operating margins and EPS on a non-GAAP basis in fiscal 2025.
Dolby held $824.4 million in <a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/n38597868/dolby-laboratories-reports-second-quarter-2024-financial-results" rel="noreferrer noopener">cash and equivalents as of March 29, 2024</a>.
The transaction includes complementary assets that enhance Dolby&#8217;s patent portfolios and will not alter Dolby&#8217;s policy of returning capital to shareholders through quarterly dividends and stock repurchases to counterbalance dilution from stock-based compensation.
Price Action: DLB shares are trading higher by 0.14% at $80.07 at the last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Asset Sales

General

Dolby Laboratories To Acquire GE Licensing In $429M Cash Deal: Strengthens Patent Portfolio

Acquisition to strengthen Dolby's licensing businesses and create opportunity for future growth
SAN FRANCISCO, June 6, 2024 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>), a leader in immersive entertainment experiences, announced today that it has entered into a definitive agreement to acquire GE Licensing, which owns, maintains, and licenses an extensive portfolio of IP primarily targeting the consumer digital media and electronics sectors.
&nbsp;
Financial Considerations&nbsp;
Dolby Laboratories has agreed to acquire GE Licensing, an intellectual property licensing business primarily targeting the consumer digital media and electronics sectors, in a $429 million all cash transaction. This deal is expected to close by the end of fiscal year 2024, subject to regulatory approval and other customary closing conditions, and is not expected to have a material impact on Dolby's fiscal year 2024 results.&nbsp;This transaction includes attractive complementary assets that strengthen and expand Dolby's patent portfolios, and represents a compelling financial profile of durable, high-margin revenue. Dolby expects the deal to be accretive on a non GAAP basis to operating margins and EPS in fiscal 2025.

Dolby Laboratories To Acquire GE Licensing, An IP Licensing Business Primarily Targeting The Consumer Digital Media And Electronics Sectors, In A $429M All Cash Transaction

Dolby Laboratories Q4 2024 Earnings Preview

Here are the major earnings after the close today

Dolby Laboratories Non-GAAP EPS of $0.81 beats by $0.11, revenue of $305M misses by $2.94M

Sees Q1 revenue $330M-$360M, consensus $337.96M. Sees Q1 Licensing revenue $305M-$335M; Gross margins 87% on a GAAP basis and approximately 90% on ...

Dolby sees Q1 non-GAAP EPS 96c-$1.11, consensus $1.09

Reports FY25 revenue $1.33B-$1.39B, consensus $1.33B. Sees FY25 Gross margins 87% on a GAAP basis and 90% on a non-GAAP basis; Operating expenses $...

Dolby sees FY25 non-GAAP EPS $3.99-$4.14, consensus $3.80

Reports Q4 revenue $305M, consensus $307.94M. "We are pleased with the progress we made in FY24," said Kevin Yeaman, President and CEO, Dolby (DLB)...

Dolby reports Q4 non-GAAP EPS 81c, consensus 70c

Reports Q1 revenue $330M-$360M, consensus $337.96M. Sees Q1 Licensing revenue $305M-$335M; Gross margins 87% on a GAAP basis and approximately 90% ...

Dolby sees Q1 non-GAAP EPS 96c-$1.11, consensus  $1.09

Dolby Laboratories, Inc. (DLB) Q4 2024 Earnings Call Transcript

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp; HIGHER AFTER EARNINGS – KORE Group Holdings&nbsp;(KORE)&nbs...

Closing Bell Movers: Keysight up 9% after Q4 earnings beat

Dolby Laboratories ( ($DLB) ) has released its Q4 earnings. Here is a breakdown of the information Dolby Laboratories presented to its investors. D...

Dolby Laboratories Reports Strong Fiscal 2024 Performance

AVAV

AZTA

FLEX

SGMO

Press Releases

Dolby Laboratories Announces Agreement to Acquire GE Licensing from GE Aerospace

Entertainment

Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2024 Financial Results

Warner Bros. Pictures Partners With AMC Theatres and Dolby to Return Matt Reeves' "The Batman" to Select Big Screens Worldwide, in Anticipation of the Upcoming Debut of the HBO Original "The Penguin" on Max

Comments

Dolby Laboratories

매도 수량

Dolby Laboratories (NYSE:DLB) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌